Serial 87748391
Live / Registered — Registered (as of 07 Dec 2021)
What this means for you
Registered since 07 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87748391
- Registration number
- 6583771
- Mark type
- Design / logo
- Filed
- 09 Jan 2018
- Published for opposition
- 04 Sept 2018
- Registered
- 07 Dec 2021
- Attorney of record
- Shauna M. Wertheim
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations
- Class 009 — Scientific and electric apparatus: next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry
- Class 042 — Scientific and technological services: Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice
- Class 044 — Medical, beauty and agricultural services: healthcare
Owner
- GRITSTONE BIO, INC., Jackson, WY, US
- GRITSTONE BIO, INC., EMERYVILLE, CA, US
- Gritstone Oncology, Inc., Emeryville, CA, US
- Gritstone Oncology, Inc., Emeryville, CA, US
Prosecution history
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Oct 2021 — USE AMENDMENT FILED
- 26 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 23 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2021 — SOU EXTENSION 5 GRANTED
- 29 Apr 2021 — SOU EXTENSION 5 FILED